X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-06 | ZYME | Moore Paul Andrew | Chief Scientific Officer | S - Sale+OE | $14.92 | -21,200 | 23,333 | -48% | -$316,391 | |||||
| DM | 2024-01-05 | ZYME | Moore Paul Andrew | Chief Scientific Officer | S - Sale+OE | $10.79 | -9,799 | 7,367 | -57% | -$105,699 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |